Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: Subgroup analysis and follow-up measurements

Archives of Neurology

Volumn 55, Issue 7, 1998, Pages 931-936

  Block, Wolfgang ^a   Karitzky, Jochen ^a   Träber, Frank ^a   Pohl, Christoph ^a   Keller, Ewald ^a   Mundegar, Rustam R ^a   Lamerichs, Rolf ^b   Rink, Hermann ^a   Ries, Fernand ^a   Schild, Hans H ^a   Jerusalem, Felix ^a  

^a UNIVERSITY OF BONN   (Germany)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MOTOR CORTEX; MOTOR NEURON DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOTOR CORTEX; PROTONS;

EID: 15144347054     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.7.931     Document Type: Article

References (23)

1. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis: Amyotrophic Lateral Sclerosis/ Riluzole Study Group II. Lancet. 1996;347:1425-1431.
2. Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol. 1994;36:40-47.
3. 1H-MR-spektroskopische Bildgebung bei Patienten mit klinisch gesichertem Morbus Alzheimer. Fortschr Röntgenstr. 1995; 163:230-237.
4. Tracey I, Carr CA, Guimaraes AR, et al. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex. Neurology. 1996;46:783-788.
5. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology. 1994;44:1933-1938.
6. Jones AP, Gunawardena WJ, Coutinho CMA, et al. Preliminary results of proton magnetic resonance spectroscopy in motor neuron disease (amyotrophic lateral sclerosis). J Neurol Sci. 1995;129(suppl):85-89.
7. Lloyd C, Chaudhuri KR, Dawson J, et al. Magnetic resonance spectroscopy studies in motor neuron disease. J Neurol. 1995;1 (suppl):30.
8. Giroud M, Walker P, Bernard D, etal. Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol Res. 1996;18:241-243.
9. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology. 1997;48:878-881.
10. Brooks BR. World Federation of Neurology Research Group on Neuromuscular Disorders: EI Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(suppl):96-107.
11. Bottomley PA. Spatial localization in NMR spectroscopy. Ann N Y Acad Sci. 1987; 508:333-348.
12. Shen JF, Saunders JK. Double inversion recovery improves water suppression in vivo. Magn Reson Med. 1993;29:540-542.
13. 1H-MR spectroscopic imaging (MRSI) of brain lesions using improved techniques for water suppression and correction of magnetic field distortions [abstract]. In: Book of Abstracts of the 11th Meeting of the Society of Magnetic Resonance in Medicine; 1992; Berlin, Germany. Abstract 1947.
14. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991;45:37-45.
15. Tourbah A, Stievenart JL, Iba-Zizen MT, Zannoli G, Lyon-Caen O, Cabanis EA. In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis. J Neuroradiol. 1996;23:49-55.
16. Roser W, Hagberg G, Mader I, et al, Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med. 1995;33:811-817.
17. Barker PB, Breiter AN, Soher BJ, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med. 1994;32:157-163.
18. Kamo H, Haebara H, Akiguchi I, et al. A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis. Acta Neuropathol. 1987;74:33-38.
19. Murayama S, Inoue K, Kawakami H, et al. A unique pattern of astrogliosis in the primary motor area in amyotrophic lateral sclerosis. Acta Neuropathol. 1991; 82:456-461.
20. Nagy D, Kato T, Kushner PD. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J Neurosci Res. 1994;38:336-347.
21. 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol Aging. 1996;17:349-357.
22. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology. 1995;195:65-72.
23. Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol. 1997;244(suppl 2):3-14.